The 1999 Lasker Awards

Editor's Note: This year's winners of the Albert Lasker Medical Research Awards were honored for their achievements at an Oct. 1 luncheon at the Hotel Pierre in New York. Three researchers were recognized for their work on ion channels, two for their development of a novel hypertension medication, and one for a lifetime of contributions to neuroscience. Following are three stories on the winners. More information is available on the Web at www.laskerfoundation.org. Basic Award Recognizes Ion Ch

Written byEugene Russo
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share



In the 1950s, Sirs Alan Lloyd Hodgkin and Andrew Fielding Huxley started to elucidate the ionic mechanisms involved in excitation and inhibition of the nerve cell membrane. Through studies in the squid giant axon, Hodgkin and Huxley, who jointly garnered the Nobel in physiology or medicine in 1963, discovered how electrical conductance controls the action of nerve cells. But they hadn't proposed a physical mechanism, a molecule-based concept for what the membrane was doing.

"A lot of people didn't care," said Hille, a professor of physiology and biophysics at the University of Washington. "But both Clay and I imagined molecules. We didn't know particularly what molecules, but we were thinking in terms of billiard balls and machines and wanted to realize it as a mechanical device." Hille and Armstrong, now a professor of physiology at the University of Pennsylvania, began working on the problem independently in 1964. They ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies